AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 20th, 2021 • EQRx, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 20th, 2021 Company Industry JurisdictionTHIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of December 17, 2021, is made and entered into by and among CM Life Sciences III Inc., a Delaware corporation (the “Company”), CMLS Holdings III LLC, a Delaware limited liability company (the “Sponsor”), the undersigned parties listed on the signature page hereto under “Existing Holders” (the “Existing Holders”), the undersigned parties listed on the signature page hereto as “New Holders” (the “New Holders” and, together with the Existing Holders and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement, a “Holder” and collectively, the “Holders”).
FORM OF INCENTIVE STOCK OPTION AGREEMENT UNDER THE EQRX, INC. 2021 STOCK OPTION AND INCENTIVE PLANQualified Stock Option Agreement • December 20th, 2021 • EQRx, Inc. • Pharmaceutical preparations
Contract Type FiledDecember 20th, 2021 Company IndustryPursuant to the EQRx, Inc. 2021 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), EQRx, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.0001 per share (the “Stock”), of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan.